Nanobiotix - ADR logo

NBTX

Nanobiotix - ADR

$4.36

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Nanobiotix - ADR post its latest quarter earnings

EPS Estimate Current Year
-1.05

Highlights

EPS Estimate Current Year:

Nanobiotix - ADR’s earning per share (EPS) estimates for the current year stand at -1.05.

Key Ratios

Key ratios of the Nanobiotix - ADR post its Q4 2021 earnings

Return on Assets (ROA)
-0.25
Return on Equity (ROE)
-0.97
Dividend Per Share (DPS)
0

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Nanobiotix - ADR’s return on assets (ROA) stands at -0.25.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Nanobiotix - ADR’s return on equity (ROE) stands at -0.97.

Dividend Per Share (DPS):

Nanobiotix - ADR declared 0 dividend per share during the earnings announcement for Q4 2021.

Company Information

Organisation
Nanobiotix - ADR
Headquarters
60 rue de Wattignies, Paris, France, 75012
Employees
89
CEO
Laurent Levy